Yttrium 90 Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy for B-Cell Non-Hodgkin's Lymphoma: Letter from the Editors

Leonard M. Freeman, M. Donald Blaufox

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1
Number of pages1
JournalSeminars in Nuclear Medicine
Volume34
Issue number1 SUPPL.1
StatePublished - Jan 2004
Externally publishedYes

Fingerprint

Radioimmunotherapy
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
ibritumomab tiuxetan

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Yttrium 90 Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy for B-Cell Non-Hodgkin's Lymphoma : Letter from the Editors. / Freeman, Leonard M.; Blaufox, M. Donald.

In: Seminars in Nuclear Medicine, Vol. 34, No. 1 SUPPL.1, 01.2004, p. 1.

Research output: Contribution to journalArticle

@article{e2f4857d652b4d6f8b900508da2606f5,
title = "Yttrium 90 Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy for B-Cell Non-Hodgkin's Lymphoma: Letter from the Editors",
author = "Freeman, {Leonard M.} and Blaufox, {M. Donald}",
year = "2004",
month = "1",
language = "English (US)",
volume = "34",
pages = "1",
journal = "Seminars in Nuclear Medicine",
issn = "0001-2998",
publisher = "W.B. Saunders Ltd",
number = "1 SUPPL.1",

}

TY - JOUR

T1 - Yttrium 90 Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy for B-Cell Non-Hodgkin's Lymphoma

T2 - Letter from the Editors

AU - Freeman, Leonard M.

AU - Blaufox, M. Donald

PY - 2004/1

Y1 - 2004/1

UR - http://www.scopus.com/inward/record.url?scp=0842324897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842324897&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0842324897

VL - 34

SP - 1

JO - Seminars in Nuclear Medicine

JF - Seminars in Nuclear Medicine

SN - 0001-2998

IS - 1 SUPPL.1

ER -